Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Choussat

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 10, 2001
[Use of heparin in unstable angina and non-Q-wave infarction]R Choussat, P Attali,
Presse Medicale (Paris, France : 1983)|July 10, 1999
[Low molecular weight heparin in unstable angina and myocardial infarction without Q wave]R Choussat, G Montalescot
Heart (British Cardiac Society)|March 20, 1998
Blocking platelets more: are we skating on thin ice?R Choussat, G Montalescot
Revue Des Maladies Respiratoires|July 25, 2000
[New medical anticoagulants]R Choussat, G Montalescot
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 26, 2002
[Non-ST acute coronary syndromes]J Ph Collet, R Choussat, G Montalescot
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 25, 2002
[Review and future perspectives on low-molecular-weight heparin]J P Collet, R Choussat, G Montalescot
European Heart Journal|August 26, 1998
Fibrinogen as a risk factor for coronary heart diseaseG Montalescot, J P Collet, R Choussat, et al.
European Heart Journal|March 25, 2000
Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade. Comparison of transradial vs transfemoral arterial accessR Choussat, A Black, I Bossi, et al.
Annales De Cardiologie Et D'Angeiologie|February 3, 2004
[Role of glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes]R Choussat, J P Collet, F Beygui, et al.
International Journal of Cardiology|March 15, 2000
A rise of troponin and/or von Willebrand factor over the first 48 h is associated with a poorer 1-year outcome in unstable angina patientsG Montalescot, J P Collet, R Choussat, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 10, 2001
[Use of heparin in unstable angina and non-Q-wave infarction]R Choussat, P Attali,
Presse Medicale (Paris, France : 1983)|July 10, 1999
[Low molecular weight heparin in unstable angina and myocardial infarction without Q wave]R Choussat, G Montalescot
Heart (British Cardiac Society)|March 20, 1998
Blocking platelets more: are we skating on thin ice?R Choussat, G Montalescot
Revue Des Maladies Respiratoires|July 25, 2000
[New medical anticoagulants]R Choussat, G Montalescot
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 26, 2002
[Non-ST acute coronary syndromes]J Ph Collet, R Choussat, G Montalescot
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 25, 2002
[Review and future perspectives on low-molecular-weight heparin]J P Collet, R Choussat, G Montalescot
European Heart Journal|August 26, 1998
Fibrinogen as a risk factor for coronary heart diseaseG Montalescot, J P Collet, R Choussat, et al.
European Heart Journal|March 25, 2000
Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade. Comparison of transradial vs transfemoral arterial accessR Choussat, A Black, I Bossi, et al.
Annales De Cardiologie Et D'Angeiologie|February 3, 2004
[Role of glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes]R Choussat, J P Collet, F Beygui, et al.
International Journal of Cardiology|March 15, 2000
A rise of troponin and/or von Willebrand factor over the first 48 h is associated with a poorer 1-year outcome in unstable angina patientsG Montalescot, J P Collet, R Choussat, et al.
Pageof 4